MENU
RYTM
AS OF
Dec 24 closing price
Price
$112.27
Change
-$0.08 (-0.07%)
Capitalization
7.49B
69 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
RYTM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Rhythm Pharmaceuticals (RYTM) Ownership - Who owns Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
222 Berkeley Street
Phone
+1 857 264-4280
Employees
226
Web
http://www.rhythmtx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.49B
P/E Ratio
N/A
Total Cash
416.05M
Projected Growth
N/A
Total Debt
4.14M
Revenue
174.33M
Risk (Beta)
1.16
Dividend Yield
N/A
Total Cash/Share
6.23
Total Debt/Equity
N/A
Revenue/Share
2.74 USD as % of share price

Fundamentals

RYTM
Capitalization
7.49B
P/E Ratio
N/A
Risk (Beta)
1.16
Dividend Yield
N/A
Total Cash
416M
Total Cash/Share
6.23
Total Debt
4.14M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.74%
Revenue
174M
ROE
N/A
Book Value
149M
P/B Ratio
50.25
Cash Flow
N/A
Earnings
-3.1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
67K
Current Ratio
4.75
Current Revenue Per Employee
181265.02
Dividends Per Share - Security
N/A
EBITDA
-169.02M
Float
N/A
Float - Current
N/A
Gross Income Margin
89.28
Revenue To Assets
-45.43
Shares Held By Institutions
14.2B
Shares Outstanding - Current
66.7M
Total Liabilities
211M
Total Volume MTD
N/A
Value
-1
Gain YTD
100.697
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
RYTM
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RYTM showed earnings on November 04, 2025. You can read more about the earnings report here.
View AI-Driven Trading for RYTM
A.I. Advisor
published General Information

General Information

a developer of peptide therapeutics for metabolic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
222 Berkeley Street
Phone
+1 857 264-4280
Employees
226
Web
http://www.rhythmtx.com